Dosilicon Income Tax Expense vs Ebitda Analysis
| 688110 Stock | 24.76 0.05 0.20% |
Dosilicon financial indicator trend analysis is much more than just examining Dosilicon latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Dosilicon is a good investment. Please check the relationship between Dosilicon Income Tax Expense and its Ebitda accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Dosilicon Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Income Tax Expense vs Ebitda
Income Tax Expense vs Ebitda Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Dosilicon Income Tax Expense account and Ebitda. At this time, the significance of the direction appears to have totally related.
The correlation between Dosilicon's Income Tax Expense and Ebitda is 0.99. Overlapping area represents the amount of variation of Income Tax Expense that can explain the historical movement of Ebitda in the same time period over historical financial statements of Dosilicon Co, assuming nothing else is changed. The correlation between historical values of Dosilicon's Income Tax Expense and Ebitda is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Income Tax Expense of Dosilicon Co are associated (or correlated) with its Ebitda. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebitda has no effect on the direction of Income Tax Expense i.e., Dosilicon's Income Tax Expense and Ebitda go up and down completely randomly.
Correlation Coefficient | 0.99 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Income Tax Expense
Ebitda
Most indicators from Dosilicon's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Dosilicon current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Dosilicon Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. As of January 6, 2025, Selling General Administrative is expected to decline to about 15.5 M. The current year's Tax Provision is expected to grow to about (43.7 M)
| 2022 | 2024 | 2025 (projected) | Interest Expense | 2.2M | 2.9M | 3.9M | Depreciation And Amortization | 33.0M | 37.9M | 30.6M |
Dosilicon fundamental ratios Correlations
Click cells to compare fundamentals
Dosilicon Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Dosilicon fundamental ratios Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 758.8M | 4.2B | 4.3B | 3.8B | 4.4B | 2.3B | |
| Short Long Term Debt Total | 83.3M | 37.5M | 43.6M | 69.5M | 62.6M | 63.0M | |
| Other Current Liab | 33.1M | 64.7M | 34.2M | 334.7K | 301.2K | 286.1K | |
| Total Current Liabilities | 99.6M | 189.8M | 184.1M | 131.9M | 118.7M | 130.3M | |
| Total Stockholder Equity | 501.4M | 3.8B | 3.9B | 3.5B | 4.0B | 4.2B | |
| Property Plant And Equipment Net | 41.1M | 78.2M | 141.6M | 136.7M | 157.2M | 165.0M | |
| Net Debt | 34.6M | (263.3M) | (3.4B) | (2.5B) | (2.2B) | (2.1B) | |
| Retained Earnings | (91.8M) | 152.4M | 232.5M | (129.7M) | (149.1M) | (141.7M) | |
| Accounts Payable | 40.7M | 95.9M | 90.5M | 52.6M | 47.3M | 57.7M | |
| Cash | 300.8M | 3.4B | 2.5B | 1.7B | 1.9B | 1.3B | |
| Non Current Assets Total | 57.1M | 117.7M | 810.6M | 972.7M | 1.1B | 1.2B | |
| Non Currrent Assets Other | 7.0M | 28.6M | 650.5M | 722.5M | 830.8M | 872.4M | |
| Cash And Short Term Investments | 48.7M | 300.8M | 3.4B | 2.5B | 2.9B | 3.1B | |
| Liabilities And Stockholders Equity | 705.6M | 758.8M | 4.2B | 4.3B | 5.0B | 5.2B | |
| Non Current Liabilities Total | 21.8M | 23.3M | 22.7M | 22.1M | 19.8M | 27.2M | |
| Inventory | 295.4M | 349.0M | 668.2M | 756.5M | 870.0M | 470.9M | |
| Other Current Assets | 4.5M | 17.0M | 118.5M | 201.4M | 231.7M | 243.2M | |
| Other Stockholder Equity | 198.7M | 261.5M | 3.2B | 3.3B | 3.7B | 3.9B | |
| Total Liab | 121.4M | 213.1M | 206.9M | 154.0M | 138.6M | 157.5M | |
| Total Current Assets | 701.7M | 4.1B | 3.5B | 2.9B | 3.3B | 2.0B | |
| Short Term Debt | 35.7M | 25.8M | 29.2M | 59.4M | 53.5M | 42.5M | |
| Intangible Assets | 936.6K | 4.0M | 3.6M | 3.0M | 2.7M | 3.3M | |
| Common Stock | 280.7M | 316.5M | 331.7M | 442.2M | 508.6M | 369.1M | |
| Net Receivables | 89.5M | 254.9M | 138.4M | 65.1M | 58.6M | 111.2M | |
| Net Invested Capital | 538.9M | 3.9B | 4.0B | 3.5B | 4.1B | 2.7B | |
| Short Long Term Debt | 25.8M | 29.2M | 59.4M | 43.0M | 49.4M | 42.5M | |
| Net Working Capital | 602.0M | 3.9B | 3.3B | 2.7B | 3.2B | 2.4B |
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in Dosilicon Stock
Balance Sheet is a snapshot of the financial position of Dosilicon at a specified time, usually calculated after every quarter, six months, or one year. Dosilicon Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Dosilicon and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Dosilicon currently owns. An asset can also be divided into two categories, current and non-current.